Bladder cancer biorepository aims to unlock secrets of tumor growth

NCT ID NCT03413982

Recruiting now Knowledge-focused Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a large registry and biorepository of information and samples from 1,000 people with bladder cancer. Researchers will collect blood, urine, and tissue samples over two years to study how they relate to tumor development, recurrence, and survival. The goal is to provide a resource for future studies that could lead to better treatments or biomarkers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help researchers find better ways to predict, treat, or monitor bladder cancer in the future.
What could go wrong: This is an observational registry, not a treatment trial. It collects data and samples for future research, so it won't directly benefit participants or produce immediate results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

University of Kansas Medical Center
RECRUITING

Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.